Long-term Follow-up of Phase 2A Trial Results Involving Advanced Ovarian Cancer Patients Treated with Vigil® in Frontline Maintenance
2020
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
7
References
10
Citations
NaN
KQI